. The OCT1, OCT2 and OCT3 expressions in human organs (http://www.proteinatlas.org).
physiology and pathophysiology and are critical key players of therapeutic response for drugs. 6 Furthermore, a number of important human drug transporters have been noted that are distributed at the apical or basal part of the epithelial cells in several tissues to orchestrate absorption, distribution and metabolism as well as drugs excretion. Importantly, membrane transporters play a considerable role in metformin absorption, distribution, and renal excretion. Multiple organic cation transporters (OCT1, OCT2 and OCT3) are determinants of the pharmacokinetics of metformin, and many of them are important in its pharmacological action, as mediators of metformin entry into target tissues. 7, 8 The OCT1, OCT2 and OCT3 are distributed in several human organs ( Figure 1 ) . Here we would like to shed light on metformin revolution in the current decade based on the completed and ongoing register clinical trials of metformin at (clinicaltrial.gov) ( Table 1) . Our analysis concerns the total clinical study of target organ of metformin according to the distribution of OCT1, OCT2 and OCT3 in human tissues. Interestingly, there are 541 completed and ongoing clinical trials of metformin on 26 target organs. However, there are no clinical trials of metformin on 11 potential target organs which can be reached by metformin such as appendix, tonsil, spleen, nasopharynx, bronchus, oral mucosa, salivary gland, small intestine, placenta, testis and soft tissue. Diverse scenarios have been manifested to illustrate the pharmacological mechanisms of metformin on different diseases for instance its metabolic effect, growth inhibition, partial inhibition of respiratory chain complex I, cell death, liver kinase B1 (LKB1)-dependent activation of AMPK, downstream of mammalian target of rapamycin (mTOR), autophagy effect, immune and hypothalamic effects. 7 Consequently, research in needing to explore the therapeutic beneficial mechanisms of metformin in the uncovered promising target organs to draw the real picture for the ongoing revolution journey of metformin as super star drug. 
